258 related articles for article (PubMed ID: 31374171)
1. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
[TBL] [Abstract][Full Text] [Related]
2. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
[TBL] [Abstract][Full Text] [Related]
3. Self-accelerating H
Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z
Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272
[No Abstract] [Full Text] [Related]
4. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
[TBL] [Abstract][Full Text] [Related]
5. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
[No Abstract] [Full Text] [Related]
6. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
[TBL] [Abstract][Full Text] [Related]
7. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
[TBL] [Abstract][Full Text] [Related]
8. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
9. Nanoclustered Cascaded Enzymes for Targeted Tumor Starvation and Deoxygenation-Activated Chemotherapy without Systemic Toxicity.
Ma Y; Zhao Y; Bejjanki NK; Tang X; Jiang W; Dou J; Khan MI; Wang Q; Xia J; Liu H; You YZ; Zhang G; Wang Y; Wang J
ACS Nano; 2019 Aug; 13(8):8890-8902. PubMed ID: 31291092
[TBL] [Abstract][Full Text] [Related]
10. A multifunctional oxygen-producing MnO
Yang C; Liu Y; Su S; Gao N; Jing J; Zhang X
J Mater Chem B; 2020 Nov; 8(43):9943-9950. PubMed ID: 33034314
[TBL] [Abstract][Full Text] [Related]
11. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
[TBL] [Abstract][Full Text] [Related]
12. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
[TBL] [Abstract][Full Text] [Related]
13. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Cancer Starvation Therapy Based on Glucose Oxidase/3-Methyladenine-Loaded Dendritic Mesoporous OrganoSilicon Nanoparticles.
Wu F; Liu Y; Cheng H; Meng Y; Shi J; Chen Y; Wu Y
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572575
[TBL] [Abstract][Full Text] [Related]
16. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
[TBL] [Abstract][Full Text] [Related]
17. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
[TBL] [Abstract][Full Text] [Related]
18. Albumin-MnO
Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
[TBL] [Abstract][Full Text] [Related]
19. Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy.
Zhang MK; Li CX; Wang SB; Liu T; Song XL; Yang XQ; Feng J; Zhang XZ
Small; 2018 Dec; 14(50):e1803602. PubMed ID: 30370690
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica-Coated Silver Nanoframes as Drug-Delivery Vehicles for Chemo/Starvation/Metal Ion Multimodality Therapy.
Zhang Y; Li Y; Gao Z; Ding B; An P; Zhang X; Sun B; Sun B
Langmuir; 2020 Jun; 36(23):6345-6351. PubMed ID: 32388995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
